Outcomes and risk factors of different treatments for neuro-cardiac and post-cardiac surgery cerebrovascular disease
Official title: Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases
Run by Beijing Anzhen Hospital · NCT07012668 · Data updated 2026-11-12
This study will look at adults with neuro-cardiac conditions or cerebrovascular problems after heart surgery to see which treatment approaches (simultaneous, staged, or conservative) are linked to better or worse outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Beijing Anzhen Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | September 19, 2024 |
| Main results expected | September 19, 2027 |
| Study ends | September 19, 2027 |
| Registry record updated | June 12, 2025 |
| Trial ID | NCT07012668 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who have neuro-co-cardiological diseases or cerebrovascular disease following cardiac surgery and who are expected to survive at least one year without other concurrent serious illnesses are ideal candidates.
✕Probably not a fit
Patients with expected survival under one year or who have multiple other serious comorbid conditions are unlikely to benefit from findings intended to guide longer-term treatment decisions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational cohort conducted at Beijing Anzhen Hospital enrolling adults with neuro-co-cardiological diseases or cerebrovascular disease after cardiac surgery. Patients receiving different management strategies (simultaneous interventional/surgical, staged interventional/surgical, or conservative care) will be followed and clinical outcomes recorded. The study will collect baseline clinical data, procedural details, and postoperative complications to identify factors associated with adverse events. Statistical comparisons and risk-factor analyses will be used to describe outcome differences between treatment approaches.
Why it matters
Potential benefit: If successful, the results could help clinicians choose between simultaneous, staged, or conservative approaches to reduce complications and improve recovery for these patients.
How similar studies have gone: Previous observational and randomized studies comparing simultaneous versus staged approaches in combined cardiac and cerebrovascular disease have shown mixed results and no definitive consensus.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years; 2. Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases. Exclusion Criteria: 1. The expected survival is less than 1 years; 2. Simultaneously merge other serious diseases;
Where it's running
-
Beijing Anzhen Hospital
Beijing, China Recruiting
Study contacts
- Study coordinator: Xiaochuan Huo, M.D.
- Email: huoxiaochuan@126.com
- Phone: +86 13716292262
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating oxygen levels in colon vascular lesions
This study is trying to see if the oxygen levels in the colon of people with certain blood vessel problems are different from those in healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.